Iadademstat + SBRT With Atezo in ES-SCLC

NCT07113691 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Interventions

DRUG: Iadademstat
DRUG: Atezolizumab
RADIATION: SBRT

Sponsor

Yale University

Collaborators

[object Object]
[object Object]